Category Archives: Press Releases


Kurin, Inc. announces clinical results on Kurin® efficacy from Central Texas Veterans Health Care System

October 16 2018 No comment

Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the Temple VA Hospital in Temple, TX, presented their findings comparing results of Kurin and Magnolia Medical’s Steripath at the recent Southwest Association of Clinical Microbiology. They are the first hospital to report on results comparing Kurin®, a passive […]

Continue Reading

Kurin, Inc. Announces Agreement with Premier for Kurin Lock® to help impact contaminated blood cultures

October 02 2018 No comment

Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that it has been awarded a Med/Surg Group agreement in the Safety Phlebotomy Category with Premier. Effective December 1, 2018 the new three-year agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by […]

Continue Reading

Kurin, Inc. Announces Educational Website on the Importance of Improving Value of the Blood Culture Test

September 18 2018 No comment

Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that it has created an educational website, www.betterbloodcultures.com, to aid clinicians in making blood culture testing more effective. Blood culture tests remain the gold standard for detecting sepsis, a bloodstream infection that is associated with significant mortality and morbidity risk. “It […]

Continue Reading

Clinical results of Kurin specimen diversion technology signal a shift in the blood culture collection standard of care.

August 31 2018 No comment

In recent months the team at Kurin, Inc., manufacturer of the only FDA cleared blood culture diversion device, has received a wealth of clinical data from early adopter hospitals. In May, Crouse Hospital in Syracuse, NY, published a 56% overall reduction in contaminated blood cultures inclusive of all cultures drawn with or without the device. […]

Continue Reading

Kurin CEO responds to Magnolia Medical Countersuit Press Release

August 17 2018 No comment

I want to take this opportunity to write to Kurin customers, the Kurin Board, employees, and our Investors. Last week, Magnolia’s CEO, Greg Bullington, issued a press release announcing counter claims Magnolia filed in early August against Kurin, Inc., and making certain inaccurate and misleading representations regarding Kurin and its products. While we are confident […]

Continue Reading

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device

July 17 2018 No comment

San Diego, CA – Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent application and has issued U.S. Patent No. 10,010,282. The Kurin blood culture collection set is a replacement for traditional collection sets, introducing technology to divert skin contaminants […]

Continue Reading

Kurin, Inc. announces clinical study results of the Kurin Lock™ blood culture initial specimen diversion device at the APIC Annual Conference.

June 13 2018 No comment

San Diego, CA: Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today at the 2018 APIC Annual Conference in Minneapolis, MN, new clinical study data supporting the efficacy of their specimen diversion device for blood culture collection. Kurin offers the only FDA 510(k)-cleared blood culture diversion product on the […]

Continue Reading

Kurin, Inc. sues Magnolia Medical for misleading consumers about FDA clearance and efficacy

May 31 2018 No comment

San Diego, CA: Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, has sued Magnolia Medical Technologies in the U.S. District Court for the Southern District of California for violations of the Lanham Act based on its false and misleading statements. In the suit, Kurin alleges that Magnolia falsely implies that […]

Continue Reading

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device

November 28 2017 No comment

Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the United States Patent Office allowed its patent application and has issued U.S. Patent No. 9,820,682. The Kurin blood culture collection set is a replacement for traditional collection sets, introducing technology to divert skin contaminants while preserving the standard […]

Continue Reading


From the creators of Curos Port Protectors

Curos is a registered trademark of 3M

Contact Us

Kurin®, Inc.
10755 Scripps Poway Parkway, Suite 257
San Diego, CA 92131
1-888-963-9056
Email Us

Copyright © 2018 Kurin Inc. All rights reserved.